EphA2 monoclonal antibody attenuates hyperoxia-induced acute lung injury by preserving the alveolar-endothelial barrier.

When comparing the two hyperoxia groups, EphA2 mAb pretreatment showed a lower BAL protein concentration relative to the PBS group; however, this difference did not reach statistical significance, indicating a trend toward reduced protein leakage.

also in 111,027 other papers